Browse Category

NYSE:RACE News 9 October 2025 - 10 December 2025

Ferrari N.V. (RACE) Stock Today: 23‑Month Low, €2 Billion Buyback Almost Done, and What Analysts Expect Next

Ferrari N.V. (RACE) Stock Today: 23‑Month Low, €2 Billion Buyback Almost Done, and What Analysts Expect Next

Ferrari’s stock is having a rough day on December 10, 2025. Despite robust margins, a nearly completed €2 billion buyback, and a long-term growth plan running to 2030, RACE shares have slumped to their lowest level in almost two years as a wave of analyst downgrades collides with an already stretched valuation. Investing.com+1 This article pulls together the key news, forecasts, and analysis on Ferrari N.V. stock as of 10 December 2025, to give a clear picture of where RACE stands now and what the market is pricing in. Ferrari stock price on 10 December 2025 As of midday trading
Ferrari Stock Skids as EV Ambitions Shift: Inside RACE’s High-Octane Gamble

Ferrari Stock Skids as EV Ambitions Shift: Inside RACE’s High-Octane Gamble

Ferrari in the Headlines: New Strategic Plan & Stock Shock In early October 2025, Ferrari N.V. held a high-profile Capital Markets Day (investor day) in Maranello, unveiling its 2030 strategic plan and updated guidance. The event proved dramatic – Ferrari’s stock plunged nearly 12% in its worst single-day drop since the company’s 2015 IPO reuters.com. Shares were briefly halted after sliding by double-digits on October 9 reuters.com, and ultimately closed the day deep in the red. This sell-off was sparked by a mix of surprising strategic pivots and cautious long-term targets that rattled some investors, despite Ferrari simultaneously raising near-term

Stock Market Today

Philip Morris stock price: PM steadies near $183 after upbeat 2026 forecast puts Zyn battle back in view

Philip Morris stock price: PM steadies near $183 after upbeat 2026 forecast puts Zyn battle back in view

7 February 2026
New York, Feb 7, 2026, 15:18 EST — Market closed. Philip Morris International shares last stood at $182.81, up 0.45% from the prior session, after the company laid out a higher 2026 profit outlook tied to its nicotine pouch business. (Reuters) That matters now because the stock has become a referendum on whether smoke-free products can keep carrying earnings while the category gets crowded. Zyn is the big swing factor, and traders are watching for any sign that volume gains are coming at the cost of pricing power. With U.S. markets shut for the weekend, the next test comes at
AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Go toTop